HPV vaccination: the beginning of the end of cervical cancer? - A Review

HPV vaccination: the beginning of the end of cervical cancer? - A Review

Human papillomavirus (HPV) is responsible for all cases of cervical cancer, as well as a great percentage of other anogenital tumors and oropharyngeal tumors. Since the main etiologic factor for these diseases is a virus, prophylactic measures are the best way to reduce the burden caused by the infe...

Full description

Bibliographic Details
Main Authors:	Ana Paula Lepique, Tatiana Rabachini, Luisa Lina Villa
Format:	Article
Language:	English
Published:	Fundação Oswaldo Cruz (FIOCRUZ) 2009-02-01
Series:	Memorias do Instituto Oswaldo Cruz
Subjects:	human papillomavirus anogenital cancers prophylactic vaccine therapeutic vaccine clinical trial
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000100001

Similar Items

Comment on “Will HPV vaccination prevent cervical cancer”
by: Shaokai Zhang, et al.
Published: (2020-04-01)

The potential use of therapeutics and prophylactic mRNA vaccines in human papillomavirus (HPV)
by: Fatemeh Movahed, et al.
Published: (2024-05-01)

Natural history of human papillomavirus and vaccinations in men: A literature review
by: Benjamin J. Lieblong, et al.
Published: (2019-05-01)

PAPILLOMAVIRUS INFECTION: PRINCIPLE CHARACTERISTICS, CLINICAL MANIFESTATIONS, VACCINE PROPHYLAXIS
by: P. D. Lopukhov, et al.
Published: (2016-02-01)

The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
by: Anna Rosa Garbuglia, et al.
Published: (2020-02-01)

The whole story: a systematic review of economic evaluations of HPV vaccination including non-cervical HPV-associated diseases
by: Anita W. M. Suijkerbuijk, et al.
Published: (2017-04-01)

Cervical cancer prevention by vaccination: review
by: Julio Cesar González-Rodríguez, et al.
Published: (2024-04-01)

HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis
by: Violante Di Donato, et al.
Published: (2022-02-01)

Assessing Saudi women’s awareness about human papillomavirus (HPV) and their susceptibility to receive the vaccine
by: Sana S. Alqarni, et al.
Published: (2024-12-01)

A Case of Genital and Extragenital Warts Unresponsive to Immunotherapy Using Measles, Mumps, Rubella Vaccine
by: Achdiat PA, et al.
Published: (2023-11-01)

Novel Antigenic Targets of HPV Therapeutic Vaccines
by: Ditte Rahbæk Boilesen, et al.
Published: (2021-11-01)

Genital Warts in Women Vaccinated against HPV in Childhood: A Systematic Review
by: Renata Malheiro, et al.
Published: (2024-05-01)

Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives
by: Yicheng Mo, et al.
Published: (2022-07-01)

Current status and future directions for the development of human papillomavirus vaccines
by: Rui Wang, et al.
Published: (2024-06-01)

Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials
by: Chantal Sauvageau, et al.
Published: (2020-03-01)

Effectiveness of bivalent HPV vaccination against genital HPV DNA-positivity of a catch-up campaign at age 13–16 years compared to routine vaccination at age 12 years: a biennial repeated cross-sectional study
by: Johannes M. A. Kusters, et al.
Published: (2024-10-01)

New Perspectives in Therapeutic Vaccines for HPV: A Critical Review
by: Barbara Gardella, et al.
Published: (2022-06-01)

Predictors of the Therapeutic Response to Intralesional Bivalent HPV Vaccine in Wart Immunotherapy
by: Noha M. Hammad, et al.
Published: (2021-11-01)

Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT
by: Richard Gilson, et al.
Published: (2020-09-01)

Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
by: Ian N. Hampson, et al.
Published: (2024-08-01)

TUBERCULOSIS VACCINES: CURRENT STATE AND FUTURE DIRECTIONS
by: Olimpia Nicolaescu
Published: (2017-03-01)

HUMAN PAPILLOMA VIRUS. PREVENTION OF HPV-ASSOCIATED DISEASES
by: F. C. Shakhtakhtinskaya, et al.
Published: (2015-08-01)

EFFICACY OF VACCINE PREVENTION OF HPV-ASSOCIATED DISEASES AND CERVICAL CANCER IN THE MOSCOW REGION
by: V. I. Krasnopol'skiy, et al.
Published: (2016-02-01)

Recommendations of the Polish Society of Gynaecologists and Obstetricians, Polish Paediatric Society, Polish Society of Family Medicine, Polish Society of Vaccinology, Polish Society of Oncological Gynaecology, and Polish Society of Colposcopy and Pathophysiology of the Uterine Cervix on prophylactic vaccinations against infections with human papillomaviruses in Poland
by: Andrzej Nowakowski, et al.
Published: (2022-10-01)

Advancing the Fight Against Cervical Cancer: The Promise of Therapeutic HPV Vaccines
by: Qian Zheng, et al.
Published: (2025-01-01)

Epidemiology and costs of HPV infection: review of the evidence
by: Francesco Bamfi, et al.
Published: (2008-01-01)

Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial)
by: Macey L. Murray, et al.
Published: (2018-11-01)

Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine—an interrupted time series analysis from 2005 to 2010 using health insurance data
by: Kathrin Thöne, et al.
Published: (2017-08-01)

Governing HPV-related carcinoma using vaccines: Bottlenecks and breakthroughs
by: Rahul Bhattacharjee, et al.
Published: (2022-09-01)

HPV vaccine program for cervical cancer prevention: how to increase community acceptance?
by: Dedy Purwito
Published: (2023-08-01)

HPV-associated anogenital condylomas: clinical-morphological aspects and therapy principles
by: N. M. Nazarova, et al.
Published: (2018-09-01)

Human papillomavirus vaccination and the role of herd effects in future cancer control planning: a review
by: Talía Malagón, et al.
Published: (2018-05-01)

Prophylactic and therapeutic vaccine development: advancements and challenges
by: Induni Nayodhara Weerarathna, et al.
Published: (2024-11-01)

Sustained Decline in Hospitalisations for Anogenital Warts in Australia: Analysis of National Hospital Morbidity Data 2003–2020
by: Harunor Rashid, et al.
Published: (2024-04-01)

L1tag Protein Expression of Human Papillomavirus Type 18 in Two Escherichia coli Strains, in Auto-inducing Media
by: Giovet Aldama Paz, et al.
Published: (2020-01-01)

Knowledge and attitude towards HPV infection, HPV vaccination and cervical cancer among middle- and high-school students in Gwalior
by: Monika Dewan, et al.
Published: (2024-10-01)

HPV vaccines: Global perspectives
by: Gaurav Gupta, et al.
Published: (2017-06-01)

Cervical Cancer Prevention with HPV Vaccines
by: Chaivanee Kaosayapandhu
Published: (2017-04-01)

Prospectives of developing therapeutic HPV vaccines
by: Natalja M. Raevskaya, et al.
Published: (2024-10-01)

Understanding How Adolescents Think about the HPV Vaccine
by: Robyn A. Pennella, et al.
Published: (2020-11-01)